Royce & Associates LP Amphastar Pharmaceuticals, Inc. Transaction History
Royce & Associates LP
- $9.25 Billion
- Q2 2025
A detailed history of Royce & Associates LP transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Royce & Associates LP holds 283,187 shares of AMPH stock, worth $7.58 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
283,187
Previous 247,858
14.25%
Holding current value
$7.58 Million
Previous $7.19 Million
9.52%
% of portfolio
0.07%
Previous 0.08%
Shares
8 transactions
Others Institutions Holding AMPH
# of Institutions
257Shares Held
33.3MCall Options Held
18.3KPut Options Held
12.6K-
Black Rock Inc. New York, NY5.94MShares$159 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.69MShares$71.9 Million0.0% of portfolio
-
Td Asset Management Inc2.03MShares$54.4 Million0.04% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.63MShares$43.5 Million0.01% of portfolio
-
State Street Corp Boston, MA1.58MShares$42.2 Million0.0% of portfolio
About Amphastar Pharmaceuticals, Inc.
- Ticker AMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,015,200
- Market Cap $1.31B
- Description
- Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...